Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Echo IQ Limited provides cardiac diagnostics support solution in Australia. The company offers artificial intelligence-assisted diagnostics technology that enhance the diagnosis of structural heart disease, as well as Aortic Stenosis. It primarily serves physicians, health systems, and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of EIQ.AX is 0.69 and suggests 52% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell